Azacytidine + HAG Regimen vs. Azacytidine for Elderly Patients With Newly Diagnosed Myeloid Malignancy

Clinical trial NCT03873311 · UNKNOWN

Trial details

NCT number

NCT03873311

Sponsor

Shenzhen Second People's Hospital

Status

UNKNOWN

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2019-09-01

Primary completion

2022-12-01

Enrollment

114

View on ClinicalTrials.gov